Treatment involves adult patients with severe alopecia areata
News
‘Junk’ DNA may hold the key to neurological disorders
University of Lincoln and the University of Sheffield are researching how DNA could be repaired
Santhera submits marketing authorisation application for vamorolone
The anti-inflammatory treatment is for Duchenne muscular dystrophy
LEO Pharma launches ‘AD Days Around the World’
Events will raise awareness around the impact of atopic dermatitis across cultures
Alligator Bioscience announces positive safety data from ATOR-1017 study
The research involves patients with advanced solid malignancies on tumour-directed therapy
Positive in vitro results for Imutex’s FLU-v
Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine
Regulatory approval received for Evgen’s SFX-01 study
New formulation may be suitable for large-scale trials and commercial supply in the future
MHRA appoints DEKRA to certify medical devices
DEKRA has become the first organisation to complete the new designation process
Shionogi reaches primary endpoint for ensitrelvir
Positive results in COVID-19 therapy phase 3 trials show effectiveness against five symptoms
Eisai’s Lecanemab phase 3 study meets primary endpoint
Results show reduction of clinical decline in global study of people with Alzheimer’s Disease
Research reveals chaotic schedule for myeloma patients
Myeloma diagnosis can take over five months, requiring several medical consultations
Modus completes recruitment for sevuparin study
Phase 1b study evaluates effects of sevuparin on the symptoms of volunteer participants
Navigo and Mannin agree to develop a novel drug for treating COVID-19
Precision X affinity ligand will enable the efficient purification of the non-Fc fusion protein
Tilt collaborates with MSD on immunotherapy clinical trial
The study will focus on checkpoint inhibitor refractory non-small cell lung cancer
LumiraDx Partners with British In Vitro Diagnostics Association
Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance
